HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 56 filers reported holding HARROW HEALTH INC in Q1 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,285,117 | -10.3% | 159,019 | +18.9% | 0.66% | -8.5% |
Q2 2023 | $2,546,486 | -20.1% | 133,744 | -11.2% | 0.72% | -23.2% |
Q1 2023 | $3,186,886 | +113636.1% | 150,609 | -20.7% | 0.94% | +13271.4% |
Q4 2022 | $2,802 | -99.9% | 189,839 | -4.5% | 0.01% | +16.7% |
Q3 2022 | $2,399,000 | -76.6% | 198,764 | +0.6% | 0.01% | -73.9% |
Q2 2022 | $10,269,000 | +2.3% | 197,664 | +11.3% | 0.02% | +4.5% |
Q1 2022 | $10,041,000 | -23.6% | 177,520 | +15.2% | 0.02% | -26.7% |
Q4 2021 | $13,150,000 | -0.6% | 154,080 | -0.5% | 0.03% | 0.0% |
Q3 2021 | $13,226,000 | +0.4% | 154,900 | +30.1% | 0.03% | -3.2% |
Q2 2021 | $13,170,000 | +2442.5% | 119,025 | +55.0% | 0.03% | +3000.0% |
Q1 2021 | $518,000 | +5.9% | 76,775 | +7.6% | 0.00% | 0.0% |
Q4 2020 | $489,000 | +40.9% | 71,325 | +14.8% | 0.00% | – |
Q3 2020 | $347,000 | +7.4% | 62,150 | 0.0% | 0.00% | – |
Q2 2020 | $323,000 | +39.8% | 62,150 | +2.5% | 0.00% | – |
Q1 2020 | $231,000 | +16.1% | 60,650 | +164.3% | 0.00% | – |
Q2 2019 | $199,000 | – | 22,950 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,795,000 | $54,534,150 | 17.74% |
Private Capital Management, LLC | 1,416,900 | $20,360,853 | 2.41% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 91,779 | $1,318,864 | 1.86% |
Birchview Capital, LP | 150,000 | $2,155,500 | 1.84% |
Diametric Capital, LP | 286,127 | $4,111,644 | 1.72% |
Ophir Asset Management Pty Ltd | 492,179 | $7,072,612 | 1.67% |
BRAIDWELL LP | 1,808,684 | $25,990,789 | 0.82% |
Westside Investment Management, Inc. | 159,019 | $2,285,117 | 0.66% |
INVICTUS PRIVATE WEALTH, LLC | 400,066 | $5,748,948 | 0.63% |
Portolan Capital Management | 385,964 | $5,546,303 | 0.52% |